SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-188265
Filing Date
2021-06-11
Accepted
2021-06-11 07:24:33
Documents
16
Period of Report
2021-06-11
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d843751d8k.htm   iXBRL 8-K 24272
2 EX-99.1 d843751dex991.htm EX-99.1 33498
3 EX-99.2 d843751dex992.htm EX-99.2 39629
7 GRAPHIC g843751g0611075415338.jpg GRAPHIC 2805
8 GRAPHIC g843751g0611075610064.jpg GRAPHIC 2805
  Complete submission text file 0001193125-21-188265.txt   244946

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA agio-20210611.xsd EX-101.SCH 3048
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE agio-20210611_lab.xml EX-101.LAB 17373
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agio-20210611_pre.xml EX-101.PRE 10938
9 EXTRACTED XBRL INSTANCE DOCUMENT d843751d8k_htm.xml XML 3236
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Filer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36014 | Film No.: 211009956
SIC: 2834 Pharmaceutical Preparations